Viewing Study NCT03611595

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:14 PM
Ignite Modification Date: 2026-02-17 @ 11:00 PM
Study NCT ID: NCT03611595
Status: RECRUITING
Last Update Posted: 2025-08-28
First Post: 2018-07-26
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Cabozantinib in Combination With 13-cis-Retinoic Acid in Children With Relapsed or Refractory Solid Tumors
Sponsor: Peter Zage
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None 13-cis-Retinoic Acid View
None Children View
None Relapsed Solid Tumors View
None Refractory Solid Tumors View
None Solid Tumors View
None cancer View
None cabozantinib View